Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Gujrathi Sheila Create: Alert

All | News | Filings
Date FiledTypeDescription
06/16/2023 4 Gujrathi Sheila (Director) has filed a Form 4 on Janux Therapeutics, Inc.
Txns: Granted 12,500 options to buy @ $13.22, valued at $165.3k
06/12/2023 4 Gujrathi Sheila (Director) has filed a Form 4 on Ventyx Biosciences, Inc.
Txns: Granted 15,937 options to buy @ $34.83, valued at $555.1k
04/26/2023 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
03/31/2023 4 Gujrathi Sheila (Director) has filed a Form 4 on Ventyx Biosciences, Inc.
Txns: Sold 100,000 shares @ $33.7324, valued at $3.4M
Exercised 100,000 options to buy @ $6.03, valued at $603k
02/13/2023 5 Form 5 - Annual statement of changes in beneficial ownership of securities:
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Gujrathi Sheila (Director) has filed a Form 4 on Ventyx Biosciences, Inc.
Txns: Granted 13,301 options to buy @ $16.54, valued at $220k
12/03/2021 4 Gujrathi Sheila (Director) has filed a Form 4 on Ventyx Biosciences, Inc.
Txns: Granted 277,941 options to buy @ $18.65, valued at $5.2M
10/25/2021 4 Gujrathi Sheila (Director) has filed a Form 4 on Ventyx Biosciences, Inc.
Txns: Converted 32,897 shares @ $0
Converted 32,897 preferred shares @ $0
10/20/2021 3 Gujrathi Sheila (Director) has filed a Form 3 on Ventyx Biosciences, Inc.
06/10/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
02/12/2021 SC 13G Gossamer Bio, Inc. reports a 4.8% stake in GOSSAMER BIO, INC.
06/17/2020 4 Gujrathi Sheila (Director) has filed a Form 4 on Turning Point Therapeutics, Inc.
Txns: Granted 8,500 options to buy @ $65.39, valued at $555.8k
02/19/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2020 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
09/27/2019 4 Gujrathi Sheila (President & CEO) has filed a Form 4 on Gossamer Bio, Inc.
Txns: Bought 10,000 shares @ $16.798, valued at $168k
04/24/2019 4 Gujrathi Sheila (Director) has filed a Form 4 on Turning Point Therapeutics, Inc.
Txns: Granted 15,000 options to buy @ $27.06, valued at $405.9k
04/16/2019 3 Form 3 - Initial statement of beneficial ownership of securities:
03/26/2019 4 Gujrathi Sheila (President & CEO) has filed a Form 4 on Gossamer Bio, Inc.
Txns: Granted 380,000 options to buy @ $22.1, valued at $8.4M
02/12/2019 4 Gujrathi Sheila (President & CEO) has filed a Form 4 on Gossamer Bio, Inc.
Txns: Converted 62,030 shares @ $0
Converted 223,182 preferred shares @ $0
Converted 55,957 preferred shares @ $0
02/07/2019 3 Form 3 - Initial statement of beneficial ownership of securities:
05/14/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/12/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
05/23/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
07/19/2013 4 Gujrathi Sheila (Chief Medical Officer) has filed a Form 4 on Receptos, Inc.
Txns: Granted 129,400 options to buy @ $18.77, valued at $2.4M
05/08/2013 3 Gujrathi Sheila (Chief Medical Officer) has filed a Form 3 on Receptos, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy